-
Please Remember: Members are only permitted to share their own experiences. Members are not qualified to give medical advice. Additionally, everyone manages their health differently. Please be respectful of other people's opinions about their own diabetes management.
Hello I am a Newbie
- Thread starter Geoff KT
- Start date
- Status
- Relationship to Diabetes
- Type 1
- Pronouns
- He/Him
Welcome to the forum @Geoff KT
The guidance from NICE around CGM for people with T2 has recently been updated, and there’s a section on blood glucose management here:
The relevant section goes into some detail (pasted below). The short answer is you might be able to access Libre on the NHS, provided you meet the criteria. And have a supportive Dr and CCG. These are guidelines for cost-effective evidence-based treatment, but they aren’t legally binding, and some areas will adopt (or reject) them faster or slower than others.
Hope this helps:
1.6.19 Consider real-time continuous glucose monitoring(rtCGM) as an alternative to isCGM for adults with insulin-treated type 2 diabetes if it is available for the same or lower cost. [2022]
1.6.20 CGM should be provided by a team with expertise in its use, as part of supporting people to self-manage their diabetes. [2022]
1.6.21 Advise adults with type 2 diabetes who are using CGM that they will still need to take capillary blood glucose measurements (although they can do this less often). Explain that is because:
1.6.23 Ensure CGM is part of the education provided to adults with type 2 diabetes who are using it (see the section on education). [2022]
1.6.24 Monitor and review the person's use of CGM as part of reviewing their diabetes care plan (see the section on individualised care). [2022]
1.6.25 If there are concerns about the way a person is using the CGM device:
The guidance from NICE around CGM for people with T2 has recently been updated, and there’s a section on blood glucose management here:
The relevant section goes into some detail (pasted below). The short answer is you might be able to access Libre on the NHS, provided you meet the criteria. And have a supportive Dr and CCG. These are guidelines for cost-effective evidence-based treatment, but they aren’t legally binding, and some areas will adopt (or reject) them faster or slower than others.
Hope this helps:
Continuous glucose monitoring
1.6.17 Offer intermittently scanned continuous glucose monitoring (isCGM, commonly referred to as 'flash') to adults with type 2 diabetes on multiple daily insulin injections if any of the following apply:- they have recurrent hypoglycaemia or severe hypoglycaemia
- they have impaired hypoglycaemia awareness
- they have a condition or disability (including a learning disability or cognitive impairment) that means they cannot self-monitor their blood glucose by capillary blood glucose monitoring but could use an isCGM device (or have it scanned for them)
- they would otherwise be advised to self-measure at least 8 times a day.
For guidance on continuous glucose monitoring(CGM) for pregnant women, see the NICE guideline on diabetes in pregnancy. [2022]
1.6.19 Consider real-time continuous glucose monitoring(rtCGM) as an alternative to isCGM for adults with insulin-treated type 2 diabetes if it is available for the same or lower cost. [2022]
1.6.20 CGM should be provided by a team with expertise in its use, as part of supporting people to self-manage their diabetes. [2022]
1.6.21 Advise adults with type 2 diabetes who are using CGM that they will still need to take capillary blood glucose measurements (although they can do this less often). Explain that is because:
- they will need to use capillary blood glucose measurements to check the accuracy of their CGM device
- they will need capillary blood glucose monitoring as a back-up (for example when their blood glucose levels are changing quickly or if the device stops working).
Provide them with enough test strips to take capillary blood glucose measurements as needed. [2022]
1.6.23 Ensure CGM is part of the education provided to adults with type 2 diabetes who are using it (see the section on education). [2022]
1.6.24 Monitor and review the person's use of CGM as part of reviewing their diabetes care plan (see the section on individualised care). [2022]
1.6.25 If there are concerns about the way a person is using the CGM device:
- ask if they are having problems using their device
- look at ways to address any problems and concerns to improve their use of the device, including further education and emotional and psychological support. [2022]
- monitoring who is using CGM
- identifying groups who are eligible but who have a lower uptake
- making plans to engage with these groups to encourage them to consider CGM. [2022]
- Status